Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

(2011) M. R. Posner et al.   ANNALS OF ONCOLOGY

Polymerase Chain Reaction Detection of HPV in Squamous Carcinoma of the Oropharynx

(2010) Elin S. Agoston et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Evolution of type-specific immunoassays to evaluate the functional immune response to GARDASIL®, a vaccine for Human Papillomavirus types 16, 18, 6, and 11

(2010) Judith F. Smith et al.   Human vaccines & immunotherapeutics

Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads

(2010) H. Faust et al.   JOURNAL OF GENERAL VIROLOGY

HPV-associated head and neck cancer: a virus-related cancer epidemic

(2010) Shanthi Marur et al.   LANCET ONCOLOGY

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays

(2010) Martha Luevano et al.   VIROLOGY

Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening

(2009) Elizabeth Ralston Howe et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications

(2009) C. H. Chung et al.   CLINICAL CANCER RESEARCH

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

(2009) Elaine M. Smith et al.   INTERNATIONAL JOURNAL OF CANCER

Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays

(2009) Jessica Wong et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004

(2009) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers?

(2008) E. M. Smith et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival

(2008) E. M. Smith et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16-Positive and Human Papillomavirus 16-Negative Head and Neck Squamous Cell Carcinoma

(2008) Y. Agrawal et al.   CLINICAL CANCER RESEARCH

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers

(2008) Miriam Reuschenbach et al.   INTERNATIONAL JOURNAL OF CANCER

Application of Protein Microarrays for Multiplexed Detection of Antibodies to Tumor Antigens in Breast Cancer

(2008) Karen S. Anderson et al.   JOURNAL OF PROTEOME RESEARCH

Next-generation high-density self-assembling functional protein arrays

(2008) Niroshan Ramachandran et al.   NATURE METHODS

Tracking humoral responses using self assembling protein microarrays

(2008) Niroshan Ramachandran et al.   Proteomics Clinical Applications

WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24–25 January 2008, Geneva, Switzerland

(2008) Morag Ferguson et al.   VACCINE

Interaction of human papillomaviruses with the host immune system: A well evolved relationship

(2008) Ian H. Frazer   VIROLOGY